Aspen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ASPEN, and what generic and branded alternatives to ASPEN drugs are available?
ASPEN has eleven approved drugs.
Drugs and US Patents for Aspen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen | CENESTIN | estrogens, conjugated synthetic a | TABLET;ORAL | 020992-001 | Jun 21, 2002 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-005 | Apr 27, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aspen | CENESTIN | estrogens, conjugated synthetic a | TABLET;ORAL | 020992-004 | Mar 13, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aspen Global Inc | ORGARAN | danaparoid sodium | INJECTABLE;INJECTION | 020430-001 | Dec 24, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aspen Global Inc | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 204713-002 | Apr 14, 2015 | AA | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aspen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-005 | Apr 27, 2007 | 6,855,703 | ⤷ Try a Trial |
Aspen | CENESTIN | estrogens, conjugated synthetic a | TABLET;ORAL | 020992-004 | Mar 13, 2000 | 5,908,638 | ⤷ Try a Trial |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-004 | May 10, 2004 | 6,855,703 | ⤷ Try a Trial |
Aspen | CENESTIN | estrogens, conjugated synthetic a | TABLET;ORAL | 020992-002 | Mar 24, 1999 | 5,908,638 | ⤷ Try a Trial |
Aspen Global Inc | ORGARAN | danaparoid sodium | INJECTABLE;INJECTION | 020430-001 | Dec 24, 1996 | 5,164,377 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ASPEN drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 0.625 mg | ➤ Subscribe | 2009-03-02 |
➤ Subscribe | Tablets | 1.25 mg | ➤ Subscribe | 2008-11-03 |
➤ Subscribe | Tablets | 0.3 mg, 0.45 mg and 0.9 mg | ➤ Subscribe | 2009-03-19 |
Similar Applicant Names
Here is a list of applicants with similar names.